Proteogenomic strategies to advance drug development and precision medicine

Proteogenomic strategies to advance drug development and precision medicine

Speakers:  Professor Ulf Gyllensten (Uppsala University) & Dr. Anders Mälarstig (Pfizer Sweden)

During the webinar, the speakers:

  • Discussed how covariates (genetic, environmental, and clinical) can affect the levels of potential biomarkers
  • Explored the use of covariate modeling to establish personally normalized plasma protein profiles (PNPPP) to reduce non-disease-related variation and maximize clinical potential
  • Described how protein quantitative trait loci (pQTLs) can provide insights into disease biology and improve the efficiency of drug development


To access this webinar, as well as the rest of our categorized library of more than 20 high-quality scientific webinars featuring presentations by leading researchers in their respective fields, please click the button below.

2947

Biomarker assays

~881 million

Protein data points generated

997

Publications listed on website

Contact us!